Home
Career Stage
Medical Students Residents Attendings CPT Codes Resources Blog Support

J3060 Injection, taliglucerase alfa 10 u

J Codes (Drugs)

Also known as: taliglucerase, Elelyso, enzyme replacement therapy

Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.

In Plain Language

genetic storage disease treatment; enzyme replacement infusion

Clinical Context

Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.

RVU Information

CPT J3060 does not have a physician work RVU assigned by CMS. This is typical for supply, drug, and equipment codes — reimbursement is based on Average Sales Price (ASP), fee schedules, or payer contracts rather than the RVU system.

Billing & Documentation

J-codes represent drugs administered by a healthcare provider (not self-administered). Documentation must include the drug name, dosage, route of administration, and medical necessity. Most payers require the National Drug Code (NDC) on the claim. Bill the appropriate administration code (96365-96379) in addition to the drug code.

Specialties

Hematology/OncologyRare Disease SpecialistsGenetic Medicine

Frequently Asked Questions

What is CPT code J3060?

CPT J3060 (Injection, taliglucerase alfa 10 u) is a J Codes (Drugs) code. Taliglucerase alfa (Elelyso) 10 units injection is a recombinant enzyme replacement therapy for Gaucher disease, a lysosomal storage disorder affecting glucocerebroside metabolism.

How is J3060 administered?

CPT J3060 is administered by a healthcare provider, typically via injection or infusion. Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy. It is used by Hematology/Oncology, Rare Disease Specialists, Genetic Medicine.

When is CPT J3060 used?

Used in Gaucher disease Type 1 and Type 3 patients with visceral and hematologic manifestations. Reduces hepatosplenomegaly and bone disease. Administered intravenously as enzyme replacement therapy.

Track This Code in RVU Edge

Log procedures, calculate wRVUs, and export board-ready case logs — all in one app.

CPT® is a registered trademark of the American Medical Association. Data sourced from CMS Physician Fee Schedule RVU26A. Descriptions, synonyms, and clinical context are original content by RVU Edge.